In the current ongoing pandemic situation; remote operations have become a necessity for business continuity. Document approval is obligatory to grant any authorization for many of pharmaceutical GxP operations.
Throughout remote document approval & electronic document management operations, there are certain repetitive challenges, errors, and risks noticed by regulators. Such issues are mostly repercussions of wrong solution selection or incorrect system configurations or erroneous operational practices. Hence there is acute demand to understand electronic approval & signature compliance requirements. This knowledge should aid to elect appropriate signature solutions & designing compliant processes, counting security, and compliance of sensitive GxP documents.
This is precisely why CONVALgroup is leading this webinar for the life science industry based on the MHRA guidance document (April 2020). Attend this webinar so you can evaluate & enhance your practices to remain in compliance with regulations for document control, data integrity & security.
Experienced Managing Director with a demonstrated history of working for about 30+ years across many global top 50 pharmaceutical industries.
Strong business development professional skilled in Computerized System Validation, Verification and Validation (V&V), Quality Management systems, Document Management, and GMP domains.
Senior Consultant Quality, Convalgroup (Istanbul, Turkey)
Director Operations, LSCPL Pvt. Ltd. (Convalgroup)